List view / Grid view
5 April 2018 | By European Pharmaceutical Review
The FDA has granted accelerated approval to Blincyto to treat adults and children with B-cell precursor acute lymphoblastic leukaemia (ALL)...
29 March 2018 | By ACD/Labs
Global regulatory authorities continue to push Quality-by-Design (QbD) on pharmaceutical groups and their supporting corporate informatics infrastructure...
26 March 2018 | By Vetter
The CDMO is honored with an international industry prize...
23 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy...
22 March 2018 | By ACG group
ACG is the ‘world’s only market ready Track & Trace solutions provider', in accordance with the EU Falsified Medicines Directive (EUFMD) - which comes into effect in February 2019...
9 March 2018 | By European Pharmaceutical Review
The FDA has approved Trogarzo for adult patients whose HIV infections cannot be successfully treated...
1 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
New permanent building to be completed by 15 November 2019...
27 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Drugs normally used to treat cancer could reduce the disfigurements of thousands of children born with life-threatening blood vessel defects...
27 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Amglidia is a new formulation of glibenclamide, specifically developed for use in newborns, toddlers and children...
27 February 2018 | By European Pharmaceutical Review
In this issue: DNA microarray for detecting, identifying and determining antimicrobial-resistant bacteria; the advantages of single-use technology and a framework for an implementation strategy; risk management when designing chemical safety assessments for pharmaceutical packaging systems.
26 February 2018 | By European Pharmaceutical Review
Scientists in California have undertaken studies that have demonstrated the effectiveness of a sophisticated algorithm in preventing the spread of infectious diseases. The application of AI allows authorities to identify the best use of resources and highlight subtle interaction points that might otherwise be missed.
21 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Imfinzi for the treatment of patients with stage III non-small cell lung cancer whose tumours are not able to be surgically removed and whose cancer has not progressed after treatment...
16 February 2018 | By European Pharmaceutical Review
NICE has issued its final appraisal decision recommending reimbursement of Lenvima for the treatment of progressive, locally advanced or metastatic, differentiated thyroid carcinoma...
13 February 2018 | By Kaiser Optical Systems
Continuous manufacturing approaches have been gaining interest in the pharmaceutical industry. They allow shorter production times, enable novel reaction pathways, increase assurances of product quality and help to realise cost savings...
12 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Biktarvy a once-daily single-tablet regimen for the treatment of HIV-1 infection...
Send this to a friend
Follow: